Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: J Nucl Med. 2014 Feb 27;55(4):657–664. doi: 10.2967/jnumed.113.126664

FIGURE 4.

FIGURE 4

Uptake of HPLC-purified 18F-FASu in EL4 and SKOV-3 cells in vitro. (A) EL4 cells were evaluated for uptake of 3H-l-ASu and 18F-FASu in absence or presence of 1 mM l-Glu or l-ASu for 30 min. Uptake and inhibition profiles were similar for both radiolabeled compounds. Values are normalized to uptake of each agent in phosphate-buffered-saline-alone control (mean ± SD, n = 4). (B) 18F-FASu uptake in SKOV-3 cells in absence and presence of 0.5 mM sulfasalazine was evaluated with 5-, 20-, 40-, and 60-min incubations. Uptake values are raw CPM values per sample (mean ± SD, n = 3). SSZ = sulfasalazine.

HHS Vulnerability Disclosure